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Abstract
Background: In Malawi, early retention in HIV care remains challenging. Depression is strongly associated with
reduced anti-retroviral therapy (ART) adherence and viral suppression. Appropriate depression care for people
initiating ART is likely to be supportive of early and continued engagement in the HIV care continuum. This paper
aims to provide an overview of a task-shifting program that integrates depression screening and treatment into HIV
care and the strategy used to evaluate this program, describes the implementation process, and discusses key
challenges and lessons learned in the first phase of program implementation.
Methods: We are implementing a program integrating depression screening and treatment into HIV care initiation
at two clinics in Lilongwe District, Malawi. The program’s effect on patients’ depression and HIV outcomes will be
evaluated using a multiple baseline pre-post study. In this manuscript, we draw from our experiences as program
implementers and some of the quantitative data to describe the process of implementation and key lessons
learned.
Results: We successfully implemented the screening phase of this program at both clinics; 88.3 and 93.2% of newly
diagnosed patients have been screened for depression at each clinic respectively. 25% of enrolled patients reported
symptoms of mild-to-severe depression and only 6% reported symptoms of moderate-to-severe depression. Key
lessons learned from the process show the importance of utilizing existing processes and infrastructure and
focusing on iterative and collaborative learning. We continued to face challenges around establishing a sense of
program ownership among providers, developing capacity to diagnose and manage depression, and ensuring the
availability of appropriate medication. Our efforts to address these challenges provide insight into the technical and
managerial support needed to prepare for, roll out, and sustain integrated models of mental health and HIV care.
Conclusions: This activity demonstrates how a depression screening program can successfully be integrated into
HIV care within the public health system in Malawi. While this program focuses on integrating depression
management into HIV care, most of the lessons learned could apply to integration of mental health into any
non-psychiatric specialist setting.
Trial registration: ClinicalTrials.gov ID [NCT03555669]. Retrospectively registered on 13 June 2018.
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Background
In Malawi a growing body of research is beginning to
document the scope of mental health challenges in the
general Malawian population. In Malawian primary care
settings, 28.8% of all patients (regardless of human im-
munodeficiency virus (HIV) status) have a common men-
tal disorder [1]; the most common condition appears to
be depression. Prevalence estimates of depression among
populations living with HIV vary: 19% among adolescents
attending HIV clinics [2]; 16% among newly initiating
ART adults; and 9% among adults on anti-retroviral ther-
apy (ART) for at least 6 months [3]. However, the lack of
national data documenting the magnitude of mental
health problems has historically hampered efforts to se-
cure and allocate resources for mental health services.
Mental health care infrastructure and human resources in
Malawi are limited; there are only four mental health facil-
ities in the country (two public and two private), − only
three of which are currently operational – all located in
urban centers. Mental health care is treated as a special-
ized service in Malawi and is primarily offered from these
aforementioned facilities.
In response to the public health burden of mental health
disorders in Malawi, Malawi’s Health Sector Strategic Plan
(HSSP 2011–2016) formally recognized the need to ad-
dress non-communicable diseases (NCDs) in Malawi [4]
and established the NCDs and Mental Health Unit of the
Ministry of Health (MOH) in the 2011–12 financial year.
Further, the 2017–2022 Malawi Health Sector Strategic
Plan prioritizes treatment for mental health, including de-
pression treatment, under their Essential Health Package
[5, 6]. The NCDs and Mental Health Unit of the MOH
developed action plans to 1) integrate mental health ser-
vices into other general health services; 2) improve the
capacity of general health care workers through training
to diagnose and manage mental health conditions at
different levels of care; and 3) raise awareness of mental
health disorders and treatment among the general popula-
tion through community health workers, teachers, reli-
gious leaders, peer educators and the media [7]. As a
result of these efforts, a pilot program aimed at building
the mental health capacity of community health workers,
encouraging community-level mental health promotion
and detection, and integrating these community health
worker activities into the primary care setting was success-
fully implemented in Zomba, Malawi [8–10]. However,
further efforts are needed to effectively realize the MOH’s
mental health goals.
Simultaneously, early retention in HIV care is a major
obstacle to achieving the Joint United Nations Programme
on HIV/AIDS (UNAIDS) 90–90-90 goals [11–13]. The
first year of ART is a particularly vulnerable period: nearly
a quarter of people initiating ART are lost to care within
the first 12 months [11–13]. Among people initiating
ART, those with comorbid depression are a large and
especially vulnerable population. Depression affects 18
to 30% of patients receiving HIV care in Africa [14] and
is an important barrier to early ART retention [15, 16].
Depression is also strongly associated with reduced
ART adherence and viral suppression [14, 17–20] as
well as greater perceived stigma and faster HIV clinical
progression [17, 20–23] and suicide [24–26]. While evi-
dence of the impact of depression treatment on HIV
care retention and treatment outcomes in Africa is cur-
rently lacking, a burgeoning body of research suggests
appropriate depression care for people initiating ART is
likely to be important for early and continued engage-
ment in the HIV care continuum [15, 27–29].
There has been a recent push to integrate mental
health services into existing primary and community
health services to address the mental health burden
among people living with HIV in resource limited settings
[30–32]. In sub-Saharan Africa, where research on inte-
grating services has been limited, task-shifting approaches
are an effective, cost-effective, and practical means of
managing depression [30, 33]. In Zimbabwe and South
Africa, training lay health workers to provide psychosocial
therapy to people living with HIV was effective at redu-
cing symptoms of depression [34, 35]. In Cameroon and
Tanzania, training HIV care providers to prescribe and
manage antidepressant treatment proved effective at im-
proving depression outcomes [36–38]. These findings sug-
gest that integrating depression screening and treatment
in HIV care services in sub-Saharan Africa is both feasible
and acceptable.
In light of the particular vulnerability to depression of
people living with HIV and the Malawian government’s
commitment to addressing mental health, the Malawi
MOH proposed integrating depression screening and
treatment into HIV care using a task-shifting model. The
MOH designed a pilot treatment program in partnership
with the University of North Carolina (UNC) at Chapel
Hill, UNC Project-Malawi, and Lighthouse Trust with the
generous support of the United States President’s Emer-
gency Plan for AIDS Relief (PEPFAR) through the
United States Agency for International Development’s
(USAID) Supporting Operational AIDS Research (Pro-
ject SOAR). The treatment program combines two
resource-efficient, context-appropriate depression treat-
ment models — algorithm-based care for depression
(ABCD) medication management and problem-solving
therapy (PST) — into a single, stepped-care program
that will be offered to patients newly initiating anti-
retroviral treatment (ART) and who have depressive
symptoms. While a few studies from the sub-Saharan
region have proven the feasibility, acceptability, and
effectiveness of integrating depression management
into HIV care [34–38], there is a dearth of practical
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guidance on how to design, implement and evaluate
such programs. To fill this knowledge gap, this paper
provides an overview of the methods used to design
Malawi’s pilot program including a description of the
program itself, the site selection, the evaluation strat-
egy, and ethical considerations. We then describe the
resulting implementation process and key challenges
and lessons learned in the first phase of program imple-
mentation drawing both from our own experiences and
some of the initial quantitative data collected.
Methods
Program overview, site selection, evaluation design
Program overview
We designed the program to be implemented in two
phases – a screening phase and an intervention phase.
Throughout the entirety of the program, all adult patients
who present for HIV testing and counseling (HTC) and
test positive for HIV are screened for depression. The pro-
gram excluded pregnant women who test for HIV at the
maternity ward as part of antenatal care.
At the beginning of the screening phase, the program
team held an in-person, lecture-style training to teach pro-
viders to screen patients for depression and re-oriented
providers to the standard care options for managing
depressed patients, namely, referral for counseling and
prescription of antidepressants (amitriptyline). As well,
the team taught providers how to recognize, triage, and
respond to individuals with suicidal ideation. Specifically,
providers were taught how to distinguish between passive
and active suicidal thoughts, how to assess level of risk
(e.g. specific plans, means) and protective factors (e.g.
social support), and about available treatment and referral
options.
During the intervention phase, the team will train
providers to provide ABCD and community health
workers will be trained to provide PST. ABCD is a
resource-efficient, task-shifting model for delivering
high quality, effective, safe antidepressant management
in non-psychiatric settings using standardize metrics.
ABCD has been effectively incorporated into HIV care
in high-income countries [39], and more recently in
Tanzania [38], Uganda [40], and Cameroon [37].
These prior efforts among HIV-positive patients in
Sub-Saharan Africa have relied on tricyclic antidepres-
sants such as amitriptyline [37, 38] and imipramine
[40] which have demonstrated excellent safety and effi-
cacy profiles in these populations. PST is a psycho-
logical treatment that teaches patients how to identify
triggers and effectively manage stressful life events by
learning or reactivating problem solving skills [41]. PST
has also proven to be a successful depression treatment
in the region, as seen in the “Friendship Bench” project
with community health workers in Zimbabwe [42].
Site selection
The MOH is the main organization responsible for public
health care provision in Malawi. Malawi has a three-tier
public health care system which is comprised of: four cen-
tral hospitals; 28 district, community and rural hospitals;
and over 700 health centers. At the primary level, health
centers serve the majority of the country’s rural and semi
urban population. While health centers across the country
vary in size and in the range of available services, they
often house an HIV clinic, an out-patient department and
a maternal and child health department or offer such ser-
vices. At these health centers, the majority of services are
provided by nurses and clinicians who do not specialize in
one area, but rotate through every department or by com-
munity health workers. Mental health services are central-
ized and are often provided in specialized tertiary health
facilities. However, there is a dearth of specialized psychi-
atric health providers or health workers adequately trained
to treat mental disorders such as depression. To address
this shortage of human resources, the MOH is advocating
for the integration of mental health services into the pri-
mary level. Specifically, the MOH would like to build the
capacity of the nurses, clinicians and community health
workers to identify and manage mental health disorders as
part of regular service provision at public health centers.
The proposed depression screening and treatment pro-
gram is currently being implemented into two HIV clinics
– Area 18 and Area 25 – in Lilongwe, Malawi. The two
clinics were chosen by the MOH in liaison with the
Lilongwe District Health Office (DHO) which manages
the health services in the district. (Table 1) These clinics
Table 1 Clinic Characteristics
Area 18 Area 25
HTC and ART Staff ≈44 ≈62
New ART patient registered from July 2016–June 2017 1194 1768
Adult ART Clinic Tuesdays & Thursdays
Permanent Psychiatric Services Psychiatric nurse on staff none
Outreach Psychiatric services Mission clinic health held monthly
Available Medication Amitriptyline stocked irregularly Chronic supply shortage
HTC HIV testing and counseling, ART Anti-retroviral therapy
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are nested within two semi-urban primary level health
centers under Lilongwe District Health Management, in
the Central Region of Malawi. Area 25 health center
serves a catchment population of 63, 783 adults and
children while Area 18 health center has a catchment
population of 212,160 adults and children. However,
anyone can receive health services at either facilities free
of charge, regardless of where they live. Both sites use
electronic medical record (EMR) systems and host
non-governmental partners that provide technical super-
vision and support, similar to what is seen at other public
health facilities across the country. The team chose these
sites because they are considered by the MOH to be rep-
resentative of primary level health centers in the Malawian
health system and since they serve a mixed urban, semi
urban and rural population. Additionally, the availability
of EMR data will simplify the evaluation and these facil-
ities are equipped to host such a program.
Evaluation design
The program’s impact on HIV and depression outcomes
will be evaluated using a multiple baseline pre-post
study. In each clinic, screening for depression began
prior to launching the intervention phase in order to ac-
crue a comparison group. Patients who screen positive
for depression during the “screening” period will com-
prise the comparison group, while patients who screen
positive during the “intervention” period will comprise
the active treatment group. However, the intervention
will then be rolled out at different time points at the two
clinics. Thus, the baseline “screening” period for will be
longer at one clinic than for the other. (Fig. 1). We chose
a multiple baseline design as it can provide evidence of
causal relationships in settings where a randomized con-
trolled trial is not feasible. The multiple baseline design
is also stronger than a simple pre-post design because it
provides stronger control for temporal trends while also
allowing each clinic to serve as its own control.
In total, we plan to enroll 2300 new ART initiators.
Evaluation team will abstract clinical data on depression
treatment, depression outcomes, attendance of HIV
appointments, HIV treatment, and viral loads for all
consenting newly diagnosed patients from their clinical
records. This data will be cleaned and analyzed using
appropriate statistical software. The effect of depression
treatment on mental health and HIV outcomes will be
analyzed using methods appropriate for a dichotomous
outcome and a multiple baseline design. Ultimately, we
will compare mental health and HIV outcomes before
(among the screening group) and after (among the inter-
vention group) the integration of the depression treat-
ment program.
In this manuscript, we will draw on our experiences as
program implementers to describe the process of imple-
mentation and key lessons learned, and will also include
some of the initial findings from the quantitative data
collected.
Ethical considerations
The program team sought and obtained ethical approval
from both the Malawi MOH’s National Health Science
Research Committee (NHSRC) institutional review board
(IRB) and the UNC IRB.
Results
In this section we describe the implementation process
including the original stakeholder meeting and site visits,
instrument adaptation, clinic trainings, and the imple-
mentation itself (Fig. 2).
Implementation process
Stakeholder meeting
The program team hosted a mental health roundtable
discussion on January 23rd, 2017, to mobilize key stake-
holders involved in the provision of HIV and mental
health. The program implementation staff, representatives
from the MOH, UNC-Chapel Hill, UNC Project-Malawi,
the University of Malawi College of Medicine, and Light-
house Trust, and management staff from Area 18 and
Area 25 clinics attended the discussion. Over the course
of the meeting, the MOH officials provided an overview
of their mental health priorities and attendees presented
their ongoing and developing projects relating to mental
health in Malawi. The roundtable provided an opportunity
Fig. 1 Evaluation Design
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for the MOH to introduce the depression screening and
treatment program, discuss the current state of mental
health and HIV care provision, and identify key stake-
holders’ concerns and priorities. A summary document
produced from this meeting captured these key themes as
well as ideas on how to take Malawi’s broader mental
health agenda forward. The key stakeholders agreed to
come together again in the coming year to continue this
discussion in hopes of growing the nidus of investment in
mental health care in Malawi.
Site visits and clinic sensitization meetings
The implementation team visited both study sites to
meet with clinic leadership and provide mental health
sensitization trainings to clinic staff on January 25th and
26th 2017. During these site visits, the team gathered in-
formation on the clinic infrastructure, staffing of the
HTC and ART clinics, staffing of psychiatric nurses, pa-
tient flow, medication availability and supply chain.
These insights then informed the development of appro-
priate instruments and protocols.
The principal investigators led two-hour sensitization
meetings with available clinic staff. During these meet-
ings, the program team provided an introduction to de-
pression and its prevalence, its intersection with HIV,
and how it can be diagnosed and treated. These
sensitization meetings also provided the program team
an opportunity to introduce the depression treatment
program to the clinics early on and elicit staff feedback
on depression and its effect on engagement in HIV care
in Malawi.
Instrument adaptation and protocol development
The Patient Health Questionnaire-9 (PHQ-9) was the in-
strument selected to screen patients for depression. The
PHQ-9 is a widely used nine item instrument that as-
sesses the presence of nine symptoms of depression
within the previous two-weeks as specified by the Diag-
nostic and Statistical Manual of Mental Disorders IV
[43]. Each of the nine items are scored from 0 (not at
all) to 3 (nearly every day). The first two questions –
known as the Patient Health Questionnaire-2 (PHQ-2) –
capture depressed mood and anhedonia, the two core
symptoms of depression. Only if a patient scores above 0
on the PHQ-2, will that patient be assessed for the pres-
ence of the remaining seven symptoms of the PHQ-9. A
total score of 5–9, 10–14, 15–20, or 20 and above are
considered indicative of mild, moderate, moderately se-
vere, or severe depression, respectively [44]. The PHQ-9
is one of a number of mental health screening tools that
have been used in Malawi and other African countries,
including the Edinburgh Postnatal Depression Scale
(designed for the perinatal period) and the Kessler-10
and Self-Reporting Questionnaire, which screen for
common mental disorders.
The PHQ-9 was chosen because it focuses specifically
on depression, has been widely used and validated in
many different settings [45], and works well both as a
screening tool for depression as well as a longitudinal
measure to monitor response to treatment. This tool has
been validated for use in HIV-positive populations in
other countries in the region [46, 47]. While not vali-
dated, the PHQ-9 has been used in one other study in
Malawi [3].
The team augmented the standard PHQ-9 with an
additional screening protocol to probe the degree of se-
verity of suicidality in patients who screened positive
for suicidal ideation on the PHQ-9 (Additional file 1).
Both the PHQ-9 and associated suicide risk assessment
protocol were translated into Chichewa, the vernacular
language in the central region of Malawi. This has entailed
an iterative process involving the health workers to ensure
that the PHQ-9 adequately captures the depressive symp-
toms yet is culturally understandable. The translated in-
strument is currently being validated.
The team also developed clinic materials to support
implementation. After examining the HIV clinical forms
(called mastercards) used to record HIV care, the team
developed a mental health clinical form in a similar style
(Additional file 2). As well, the team developed clinic
reference guide posters to remind providers how to ad-
minister and interpret the PHQ-9. These posters hang on
the walls of the ART clinic rooms (Additional file 3).
After assessing patient flow and staffing, the program
team developed a protocol that delineated staff responsi-
bilities for screening patients and established a process for
enrolling patients in the evaluation study. This protocol
was presented to clinic leadership and staff and adapted as
Fig. 2 Implementation Timeline
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necessary. The HTC counselors screen all patients receiv-
ing HTC services who test positive for HIV with the
PHQ-2. Should that patient score above 0 on the PHQ-2,
the HTC escorts that patient to a HIV provider to admin-
ister the patient with rest of the PHQ-9. At Area 25, the
ART clinic is staffed daily, so patients are normally
escorted directly to the ART clinic. However, at Area 18,
the ART clinic is only staffed with providers on clinic days.
Thus, the HTC counselors are charged with locating an
available provider at one of the other clinic wards to ad-
minister the rest of the PHQ-9 on Mondays and Fridays.
The evaluation staff approach all patients newly diagnosed
with HIV regardless of their PHQ-2 score while they are
waiting to receive treatment or attend a group counseling
session, in an effort not to disrupt clinic flow. The staff in-
forms these patients about the program and invites them
to allow their clinical data to be abstracted and used to
evaluate the program. The evaluation staff then consents
all interested patients in a private location.
Clinic trainings
Clinic staff trainings were held on March 28th and 29th
2017. The program team members, the MOH principal
investigator and a psychiatrist led the trainings which
were attended by HIV care providers, HTC counselors,
Lighthouse and MOH staff. Thirty-four participants
attended the training at Area 18 and 43 participants
attended the training at Area 25, about 75 and 70% of
the clinics’ HTC and ART staff respectively.
The trainings provided attendees with an overview of
the study, an introduction to depression and other men-
tal health conditions, instructions on how to use the
PHQ-9, guidance on triaging and responding to suicidal
thoughts, treatment options, use of the Mental Health
Mastercard, and an overview of how screening would be
integrated into patient flow. The trainings also provided
an opportunity for staff to raise concerns with the proto-
col and voice any anticipated challenges. Since then, one
refresher training has been held at each clinic, one in
May and one in June.
Implementation
The program was piloted at both clinics on April 22nd
and 23rd 2017 and then officially launched at Area 18 on
April 24th. As of the December 1st, 2017, HTC counselors
have screened 88.3 and 93.2% of newly diagnosed patients
with the PHQ-2 at Area 18 and Area 25 clinics, respect-
ively. Of those patients who score above 0 on the PHQ-2,
Area 18 and Area 25 clinics have screened 91.4 and 88.0%
with the entire PHQ-9, respectively. Some initial chal-
lenges arose including:
– Managing patient flow on non-clinic days: With
test-and-treat, patients who test positive for HIV are
taken to the ART clinic to initiative care. If no
nurses or clinical officers were at the ART clinic,
the clerk would often give the patients ART, even
though the provision of clinical care is outside of
their prevue. On these occasions, no one at the
ART clinic was able to complete the PHQ-9 for
those with PHQ-2 scores greater than 0 or address
any resulting clinical needs. The program staff raised
this challenge with clinic leadership who instructed
the HTC counselors to bring patients to providers
in the outpatient ward to initiate ART and complete
the PHQ-9 screening if necessary. This also eliminated
the need for the clerk to provide patients with
medication.
– Inconsistent administration of the screening tools:
Some providers struggled to administer the PHQ-9
in a standardized manner which lead to inter-rater
differences in scoring. For example, the program
team observed that providers would rephrase the
questions when administering the tool and varied in
their interpretation patients responses. The research
staff provided guidance and ongoing clinical
supervision to improve inter-rater reliability.
– Discomfort treating depression: Providers expressed
to the program team that they did not feel
comfortable treating the cases of depression they
identified. Providers were instructed to manage
suspected cases of depression using existing
resources at their health centers, or refer to the
psychiatric nurse.
– Unfamiliarity with new clinical forms: The program
introduced new clinical materials clinicians were
either only introduced to during the training or
were seeing for the first time on the job. Program
staff provided guidance on using the Mental Health
Mastercard.
– Inconsistent assessment of patient with suicidal
thoughts: Initially, providers were not systematically
assessing suicide risk, but were each using their own
method to decide whether a patient needed to be
referred for more intensive psychiatric treatment.
Suicide risk assessment was translated into
Chichewa and the program team instructed
providers to focus on ascertaining whether the
patient is actually thinking of hurting themselves.
– Reluctance to integrate of depression management
into HIV care: Traditionally mental health care has
been the domain of specialized psychiatric providers
and providers are already charged with a heavy
workload. As such, some providers perceived
depression screening as an additional responsibility,
for which they were not being additionally
compensated. The program team engaged the clinic
staff on the importance of depression management
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in HIV care and worked with staff to find ways to
make the integration as easy as possible.
The team assessed the roll-out and addressed any initial
challenges before retraining and launching at Area 25 on
May 16th and 19th. As of December 1st, 2017, 1160 pa-
tients have enrolled in ART care and 1042 patients
(90%) have been screened with the PHQ-2. Of those
1042 patients who were screened, a total of 487 patients
at Area 18 and 513 at Area 25 consented to have their
clinical data used to evaluate the program. At ART ini-
tiation, 25% of patients had a PHQ-9 score of 5 or
above, indicating mild-to-severe depression. (Table 2).
Lesson learned: Successes
Formative investigation of existing processes and
infrastructure
Attention to clinic infrastructure, patient flow and
staff responsibilities Prior to developing a protocol, the
program team carefully documented the process patients
underwent when testing and initiating HIV care as well
as the existing infrastructure at both clinics. After estab-
lishing where and when patients are seen by the HTC
counselors, the group counselors, the ART registration
staff, and providers, the team identified the appropriate
staff to screen patients with the PHQ-2 and administer
the PHQ-9. They also identified the most convenient
times to consent patients for the evaluation component
without extending the amount of time they spend at the
clinics. In this manner, prior to launching the program,
the team laid groundwork to successfully implement
without interrupting patient flow or overburdening staff
and only minor tweaks to address the availability of clini-
cians and nurses were needed over the first couple weeks
of implementation.
Iterative and collaborative learning
Cultivating an iterative and collaborative learning
environment To inform clinic leadership and staff
about progress, elicit their concerns, and discuss any
challenges, the program team holds weekly meetings
alternatingly at both clinics. As well, the team holds a
weekly operations call with the program team members
from the MOH, UNC at Chapel Hill, UNC-Project, and
Lighthouse, with other key-stakeholders invited from
Baylor College of Medicine. Further highlighting the
importance of collaboration, it became evident from
the early weeks of implementation at Area 18 that the
clinics were staffed not only by MOH employed public
health providers, but by rotating staff that report to
non-governmental organizations such as Baylor and
Lighthouse. In order to assure continuity of program
knowledge, all of the rotating staff needed to be trained
on the protocol. In response, the program team trained
Baylor staff in early September, is working to coordinate
orientation training for Lighthouse staff, and communi-
cates weekly with Baylor and Lighthouse leadership.
Lessons learned: Challenges
Fostering ownership
Developing clinical ownership of the program One of
the key challenges the team faced during implementa-
tion has been clinic resistance to additional responsibil-
ities without additional compensation or incentives. This
is unsurprising, as the most visible staff are the evalua-
tors employed by UNC-Project Malawi, an organization
that has been involved in public health research in the
region for over three decades. In response, the team has
continuously emphasized to the clinic staff that the
project is a government initiative and has had MOH
representation at clinic sensitization meetings, orienta-
tion trainings, refreshers and many of the weekly clinic
meetings. As well, the team engaged with the Lilongwe
DHO and now a District Health Management Team
(DHMT) representative is a permanent member of the
program team. To supplement this effort, the program
team identified supportive clinic staff who demonstrated
an ability to support their colleagues implement the
screening initiative and nominated these individuals to
become on-the-ground mental health champions. These
individuals will champion the implementation of the pro-
gram in the clinics. Ultimately, the extent to which clinic
staff and leadership accept this program as government
initiative and part of their responsibility as government
employees will determine its success.
Ongoing capacity building
Training clinical staff Providing quality screening and
treatment for depression to patients initiating HIV care re-
quires mental health-literate staff capable of using the
screening instruments and following treatment protocols.
Thus, to implement this program, all of the clinic staff
Table 2 Enrollment Indicators
Area 18 (N = 487) Area 25 (N = 513)
PHQ-9 Score 0 1–4a 5-9b ≥ 10c 0 1–41 5-9b ≥ 10c
Total (%) 232(48) 133(27) 95(20) 27(6) 280(55) 103(20) 99(19) 31(6)
adepressed mood and or anhedonia; bMild depression; cModerate-to-severe Depression
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involved in providing HIV care need to be trained on the
protocol, on their responsibilities in the depression screen-
ing and treatment process, and on how to use screening
tools. In fact, one of the main benefits of this program is
the mental health capacity building accomplished through
this type of continued education. However, ensuring that
all staff were available to attend the training was particu-
larly challenging. At both clinics, providers rotate through
the clinic wards, serving some weeks in the out-patient or
maternity wards, and others in the HIV clinic, and so
forth. As well, the trainings took place while the clinic was
open and operating, so many providers were unable to
leave their posts to attend. The limited and over-burdened
human resources at each clinic further exacerbated this
challenge. To ensure that all staff were appropriately
trained, the program team held multiple trainings, offered
one-on-one orientations, held a refresher training
two-months following implementation, and have planned
future refresher trainings. To reinforce these efforts, a
psychiatrist is scheduled to shadow both the HTC coun-
selors and the providers while they administer the PHQ-2
and PHQ-9. This will provide continued opportunities for
one-on-one feedback and training.
Mobilization of human resources and medication supplies
Provision of specialized psychiatric services Imple-
menting this program has also highlighted the importance
of maintaining a functioning referral system for accessible
psychiatric care and ensuring the availability of psychiatric
medications. To ensure that patients are able to access
and receive appropriate care for depression, the program
wanted to ensure that psychiatric care was offered at each
clinic at least once a week. This was not a challenge at
Area 18, where a psychiatric nurse is scheduled at least
once a week and rotates through the ART clinic. However,
at Area 25, psychiatric care is only offered by a private
outreach team monthly or bi-monthly. Since this chal-
lenge was identified during the orientation trainings in
March, the program team has been working with the
district health management team members to ensure a
general mental health clinic is offered weekly.
Medication availability The mental health roundtable
discussion in January 2017 raised issues around the
availability of medication to treat depression at both the
clinic and district level in Malawi during and at the time
of the initial site visits, neither of the clinics had stocked
amitriptyline or fluoxetine. Both of these drugs should
be available as part of Malawi’s Essential Health Package.
The program team began working to address challenge
immediately, months before launching the program. The
program team communicated the supply chain concerns
to the clinic leadership, who both agreed to request
amitriptyline from the Lilongwe DHO. Communication
with the clinic leadership continued, but by early April,
neither of the clinics had received a supply of amitriptyl-
ine. After discussions with the pharmacy-in-charges at
both clinics and the Lilongwe DHO, it became clear the
Lilongwe DHO pharmacy had depleted their own supply
of amitriptyline. The program’s MOH principal investiga-
tor liaised with the Malawi Central Medical Stores Trust
on the situation and learned they, too, had depleted their
stocks, but they promised to float an emergency psycho-
tropic tender. In light of the nationwide shortage, the
clinics requested that the program obtain a starter pack of
amitriptyline while waiting normal supplies. Thus, the
program bought two 1000 25 mg tablet bottles for each
clinic, approximately a 30-day supply for about 30 patients
(depending on dosage) per clinic. The MOH is continuing
to work with the DHO to ensure that amitriptyline is ap-
propriately stocked.
Effectively utilizing existing processes and clinical tools
Identifying and reassessing depressed patients The
program integrated depression management into the
paper clinical records system, but not into the EMR
system. Providers struggled to identify patients with
depression and ensure they were reassessed with the
PHQ-9 when they returned for ART care each month.
When ART patients return to receive care, providers are
meant to both update the patient’s EMR and their paper
ART Mastercard. However, providers do not necessarily
pull the patient’s ART Mastercard – and thus the Mental
Health Mastercard – opting instead to use the EMR
system, which does not prompt providers to reassess
depression. Anticipating this challenge, a green sticker is
placed on the health passport of every patient that
scores 5 or above on the PHQ-9 to help remind pro-
viders which patients are in need of depression care.
However, it became clear that returning patients were
being missed. Only some providers were aware that they
should look for the green sticker. To address this issue
early on, the program team raised this challenge at the
weekly clinic meetings and asked clinic staff to brain-
storm solutions. As a result, the clinic staff decided they
need a refresher training in June 2017, data clerks should
be instructed to look out for the green stickers and try
to help pull the appropriate files, and requested the pro-
gram team post reminders in the clinic rooms explaining
the meaning of the green sticker. As well, providers em-
power patients to call attention to the green sticker on
their health passports when they return to collect their
ART medication. As this issue has remained challenging,
signs highlighting the last four digits of the ART IDs of
depressed patients expected to return each week are also
posted in the ART clinic each week by evaluation staff,
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though this solution is not sustainable. As well, the pro-
gram team is investigating whether a new module for
the EMR system can be developed in recognition that
the more this program can be integrated into existing
systems and routine clinical responsibilities, the easier it
will be for providers to implement.
Conducting implementation science research in a clinical
setting
Separation of clinical and evaluation responsibilities
A key feature of this program is that, while the evalu-
ation staff works on the ground to consent patients and
collect data, none of the evaluation staff are meant to
have any clinical responsibilities or influence the
provision of HIV or mental health care. As the clinics
are short staffed and the clinic providers are overbur-
dened, particularly at Area 18, the providers lean on the
evaluation team to help patients navigate accessing ap-
propriate care. For example, if an HTC provider is busy
and the ART clinic is not staffed (such as on Mondays
and Fridays), they will ask an evaluation staff member to
help a patient who scored above 0 on the PHQ-2 find an
available nurse or clinician in the out-patient or mater-
nity wards. As well, on the pediatric ART clinic days,
ART providers may ask newly initiating adults that need
to be screened with the PHQ-9 to wait until the end of
the day or to return the following day to receive care
unless an evaluation staff member can find an available
provider. It is particularly important for the sake of
sustainability that the evaluation team does not create
systems or provide support that would cease to exist at
the end of the program. This distinction may not be well
appreciated by the clinic staff or leadership, who fre-
quently suggest during the weekly clinic meetings that
the evaluation team support their clinical responsibil-
ities. In order to address this issue, the program team
highlights the separation of responsibilities in all of the
trainings and weekly clinic meetings and MOH investi-
gator, visiting psychiatrist and DHMT representative
continue to reinforce this message.
Ethical standards for implementation science research
As mentioned ethical approval was sought and obtained
from the Malawi MOH’s NHSRC IRB. However, the
program team proposed that the program evaluation be
considered an implementation science study. As imple-
mentation science is concerned with methods to pro-
mote the adoption and integration of evidence-based
practices into routine health care [48], the team re-
quested to waive the need for individual consent, argu-
ing the evaluation was not human research. The team
specifically contended that the program is designed to
evaluate the provision of “standard depression care,”
not an experimental treatment, and that only de-identified
clinical information would be used in the evaluation.
However, the NHSRC advised the team to proceed with
consenting stating depressed patients are a vulnerable
group and to request for a waiver should consenting inter-
fere with the evaluation or delay care. This decision may
bias the evaluation as the process of consenting patients
and returning them to the clinic flow does take time and
mildly disrupts care. It also places the evaluation team
members in a position to help patients navigate initiating
HIV treatment and depression screening, assistance new
ART initiators will not receive at the end of this project.
Implementation science is a relatively new discipline,
particularly in low and middle income countries [49]. Un-
derstanding the ethical requirements of such evaluations
as compared to other human subject research may require
continued dialogue to ensure the objectives of implemen-
tation science can be achieved.
Discussion
This activity has demonstrated how a depression
screening program can successfully be integrated into
HIV care within the public health system in Malawi.
After seven months, between 88 and 93% of all newly
diagnosed patients have been screened with the PHQ-2
and between 88 and 91% of those who score above 0 on
the PHQ-2 have been screened with the entire PHQ-9.
While limited research in the field of depression and HIV
care integration has been conducted in sub-Saharan
Africa, a few studies conducted in Tanzania, Zimbabwe,
and Cameroon demonstrated that integration is possible
[35–38]. As well, a clustered randomized control trial on
integrating depression screening and treatment into HIV
care in Uganda found that similar integration models
(another algorithm-based model versus a model where
ART clinicians individually decide how to further assess
and treat depressed patients) could be successfully
adopted and used to screen and treat depressed patients
[40]. These findings provide evidence that with careful at-
tention to implementation process HIV care providers can
successfully screen individuals initiating HIV care for
depression in Sub-Saharan Africa.
Previous prevalence estimates of depression in Malawi
ranged from 9 to 30% [1–3, 50, 51]. While 25% of pa-
tients enrolled in our program evaluation reported
symptoms of mild-to-severe depression, the evaluation
revealed a relatively low (6%) prevalence of moderate-
to-severe depression. This low prevalence may be due
to our choice of screening tool, inconsistent adminis-
tration and interpretation of the PHQ-9, or un-
accounted for differences in how Malawians express and
report symptoms of depression. Other studies have raised
similar concerns [46, 52], suggesting further research on
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differences between depression screening tools and on
cultural-constructs of depression may be warranted.
Key lessons learned from the implementation process
show the importance of utilizing existing processes and
infrastructure and focusing on iterative and collaborative
learning. As well, efforts to address challenges around es-
tablishing a sense of program ownership among the HTC
counselors and HIV providers, continuing to develop cap-
acity to diagnose and manage depression, and ensuring
the availability of appropriate medication provide insight
into the technical and managerial support needed to pre-
pare for, roll out, and sustain integrated models of mental
health and HIV care. Similarly, the small study integrating
depression treatment into HIV care in Tanzania using only
two HIV providers also found that provider comfort pre-
scribing anti-depressants and anti-depressant availability
were challenging [3, 38]. However, the randomized control
trial conducted in Uganda did stress that task-shifting
could be successful with appropriate training, supervision
and mentorship [40]. To our knowledge, no programmatic
research evaluating programs integrating depression
screening and treatment into HIV care in Sub-Saharan
Africa has been published. Further implementation sci-
ence research should be conducted in the region to better
understand how to best integrate depression management
into HIV care.
There are several limitations to this work. The results
from this manuscript largely draw on the experiences of
the implementers. While we believe it is important to
share these experiences, we also recognize that the chal-
lenges we have noticed and highlighted here may be
biased. As well, the prevalence of depression presented in
this manuscript is estimated only from those individuals
who consented to have their clinical data abstracted.
Finally, this depression screening program was tailored
for the Malawi health care context, specifically for pub-
lic HIV clinics, and, as such, some findings may not be
generalizable to other settings. However, we hope that
sharing the experience of developing and implementing
this program may serve as a guide for implementation
of other integrated NCD and HIV programs in the
region.
Conclusions
This paper describes the many factors that must be taken
into account during the implementation of a program in-
tegrating depression screening and treatment into HIV
care in Malawi. A focus on integration and collaboration
was key to successfully launching the program. However,
fostering ownership, continuing to build capacity, mobiliz-
ing human resources and medication, and determining
appropriate ethical standards for implementation science
research in a clinical setting remained challenging. While
this program focuses on integrating mental health care
into HIV care, most of the lessons learned are not specific
to HIV care, but would apply to integration of mental
health into any non-specialist setting.
Additional Files
Additional file 1: “Patient Health Questionnaire” The depression
screening tool and the suicide risk assessment protocol in both English
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Additional file 2: “Mental Health Mastercard” The clinical form used
by providers to capture mental health screening and treatment data.
(DOCX 113 kb)
Additional file 3: “Clinic Reference Guide” Posters used to remind
providers how to administer and interpret the PHQ-9. (DOCX 92 kb)
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